Anika Therapeutics appointed Susan Vogt to its board of directors.
Here are three things to know:
1. Ms. Vogt previously served as CEO and director of Aushon Biosystems, a venture-backed company with an immunoassay platform. She has more than 35 years of experience in the global life science research, pharmaceutical, biotech and clinical diagnostics industries.
2. Anika Therapeutics is an orthopedic and regenerative medicine company that develops and manufactures more than 20 products based on its proprietary hyaluronic acid technology.
3. Steven Wheeler, who has served as a director of Anika Therapeutics since 1993 and currently chairs the board's governance and nominating committee, will retire Feb. 8, 2019.